Englobal Corp (ENG) 1.83 $ENG
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 11:46AM CST
NETE: 1.16 (-0.12), ANV: 0.74 (-0.04), LXRX: 0.85 (-0.05), CYAN: 5.90 (-0.16), JMEI: 13.50 (-0.01), LQDT: 7.86 (+0.13), KIRK: 22.37 (+0.24), IMNP: 2.42 (+0.02), RMTI: 8.20 (+0.04), FES: 1.17 (+0.01), DWCH: 8.56 (-0.08), AMDA: 0.69 (-0.01), CYBX: 53.76 (+0.08), BAMM: 1.74 (-0.07), CRMT: 49.97 (-0.94), EDAP: 2.15 (+0.02), BPTH: 2.67 (+0.03), MAGS: 5.35 (+0.09), RITT: 1.10 (unch), ENG: 1.83 (-0.01)
ENGlobal Reports Third Quarter 2014 Results
GlobeNewswire - Thu Nov 06, 5:55AM CST
ENGlobal (Nasdaq:ENG), a leading provider of engineering and automation services, today announced its financial results for the third quarter and nine months ended September 27, 2014.
ENG: 1.83 (-0.01)
ENGlobal Finalizes Credit Facility With Regions Bank
GlobeNewswire - Wed Sep 17, 5:55AM CDT
ENGlobal (Nasdaq:ENG),a leading provider of engineering and automation services, announced today that it has closed on a new three-year secured revolving credit facility with Regions Bank (NYSE:RF). The Regions facility allows the Company to borrow up to $10 million pursuant to a borrowing base formula based primarily on the Company's eligible accounts receivable.
RF: 10.01 (-0.16), ENG: 1.83 (-0.01)
ENGlobal Reports Second Quarter 2014 Results
GlobeNewswire - Fri Aug 08, 5:55AM CDT
ENGlobal (Nasdaq:ENG), a leading provider of engineering and automation services, today announced its financial results for the second quarter ended June 28, 2014.
ENG: 1.83 (-0.01)
ENGlobal Tops Houston Chronicle's 100 List for Market Return
GlobeNewswire - Fri Jun 27, 5:55AM CDT
ENGlobal (Nasdaq:ENG), a leading provider of engineering and automation services, today announced it has been ranked first on the Houston Chronicle's listing of the top 100 public companies in Houston in the category of Market Return. The full article, published June 22, 2014, can be found on HoustonChronicle.com
ENG: 1.83 (-0.01)
ENGlobal Announces Annual Meeting Results
GlobeNewswire - Thu Jun 19, 4:30PM CDT
ENGlobal (Nasdaq:ENG), a leading provider of engineering and related project services, today announced the results of its 2014 annual stockholders' meeting held this morning in North Houston.
ENG: 1.83 (-0.01)
Aortic Intervention Market Report, 2014 Edition - Forecasts to 2020
M2 - Fri Dec 20, 8:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/t786w4/aortic) has announced the addition of the "Aortic Intervention Market - 2014 Edition" report to their offering. The last 20 years have seen enormous progress in the endovascular treatment of aortic pathologies. Infra-Renal abdominal aortic aneurysms can now be treated by endovascular grafts in the majority of cases, and thoracic endovascular aortic repair (TEVAR) has gained wide acceptance throughout much of the world. According to thought leaders, this decade promises to be even more exciting. Paradigms will be shifted and innovation will accelerate to meet the remaining challenges of the aorta. New concepts will be introduced to facilitate repair close to and in the aortic arch, treat both types of dissecting aneurysms and revascularize vital branches while excluding aneurysms more effectively from circulation. During the rest of the decade, thoraco-abdominal aortic endovascular aneurysm repair (TAA-EVAR) with fenestrated, branched and hemodynamic repair devices, an emerging new modality that is gathering momentum, will be perfected and devices will become simpler to use, stockable in off-the- shelf configurations and widely adopted. A new generation of devices that further expands the universe of patients eligible for endovascular repair will rollout in major markets so that before the end of the decade close to 90% of aortic aneurysm patients will be treated endovascularly. Hemodynamic repair of thoraco-abdominal aneurysms is a particularly disruptive technology platform. No fenestrations, no branches and the blood simply goes where it should. If the technology proves effective, it might make other more complicated technologies unnecessary. The Aortic Intervention Market Report attempts to answer some important questions regarding the fast evolving aortic intervention landscape. The report, which takes a novel disease management approach to the sector, analyzes revenue and growth trends for the entire market with special emphasis on major disease areas. Aortic Intervention Market Report examines Leading companies technologies, product offerings, market shares and strategic positions, uncovers areas with maturing trends as well as areas with high growth potential and provides an updated vision to 2020. With Aortic Intervention Market Report you'll be better able to: - Examine new strategic landscape and understand evolving market dynamics. - Assess market size and growth rates of leading device segments. - Re-assess market potential and have access to updated forecast. - Understand current market situation, competitors' positions and market shares. - Identify emerging technologies and the companies behind them. - Leverage your own technology and brainstorm new business opportunities. - Monitor the competition's marketed and in-development products. - Investigate mergers, acquisitions and licensing possibilities. Aortic Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this one billion dollar fast growing market. For more information visit http://www.researchandmarkets.com/research/t786w4/aortic
ENG: 1.83 (-0.01)
ENGlobal CorporationCorporate Event Announcement Notice
Wall Street Horizon - Thu Dec 19, 7:51PM CST
Trading resumes in:
ENG: 1.83 (-0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 11:46AM CST
NETE: 1.16 (-0.12), ANV: 0.74 (-0.04), LXRX: 0.85 (-0.05), CYAN: 5.90 (-0.16), JMEI: 13.50 (-0.01), LQDT: 7.86 (+0.13), KIRK: 22.37 (+0.24), IMNP: 2.42 (+0.02), RMTI: 8.20 (+0.04), FES: 1.17 (+0.01), DWCH: 8.56 (-0.08), AMDA: 0.69 (-0.01), CYBX: 53.76 (+0.08), BAMM: 1.74 (-0.07), CRMT: 49.97 (-0.94), EDAP: 2.15 (+0.02), BPTH: 2.67 (+0.03), MAGS: 5.35 (+0.09), RITT: 1.10 (unch), ENG: 1.83 (-0.01)
ENGlobal Reports Third Quarter 2014 Results
GlobeNewswire - Thu Nov 06, 5:55AM CST
ENGlobal (Nasdaq:ENG), a leading provider of engineering and automation services, today announced its financial results for the third quarter and nine months ended September 27, 2014.
ENG: 1.83 (-0.01)
ENGlobal Finalizes Credit Facility With Regions Bank
GlobeNewswire - Wed Sep 17, 5:55AM CDT
ENGlobal (Nasdaq:ENG),a leading provider of engineering and automation services, announced today that it has closed on a new three-year secured revolving credit facility with Regions Bank (NYSE:RF). The Regions facility allows the Company to borrow up to $10 million pursuant to a borrowing base formula based primarily on the Company's eligible accounts receivable.
RF: 10.01 (-0.16), ENG: 1.83 (-0.01)
ENGlobal Reports Second Quarter 2014 Results
GlobeNewswire - Fri Aug 08, 5:55AM CDT
ENGlobal (Nasdaq:ENG), a leading provider of engineering and automation services, today announced its financial results for the second quarter ended June 28, 2014.
ENG: 1.83 (-0.01)
ENGlobal Tops Houston Chronicle's 100 List for Market Return
GlobeNewswire - Fri Jun 27, 5:55AM CDT
ENGlobal (Nasdaq:ENG), a leading provider of engineering and automation services, today announced it has been ranked first on the Houston Chronicle's listing of the top 100 public companies in Houston in the category of Market Return. The full article, published June 22, 2014, can be found on HoustonChronicle.com
ENG: 1.83 (-0.01)
ENGlobal Announces Annual Meeting Results
GlobeNewswire - Thu Jun 19, 4:30PM CDT
ENGlobal (Nasdaq:ENG), a leading provider of engineering and related project services, today announced the results of its 2014 annual stockholders' meeting held this morning in North Houston.
ENG: 1.83 (-0.01)
Aortic Intervention Market Report, 2014 Edition - Forecasts to 2020
M2 - Fri Dec 20, 8:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/t786w4/aortic) has announced the addition of the "Aortic Intervention Market - 2014 Edition" report to their offering. The last 20 years have seen enormous progress in the endovascular treatment of aortic pathologies. Infra-Renal abdominal aortic aneurysms can now be treated by endovascular grafts in the majority of cases, and thoracic endovascular aortic repair (TEVAR) has gained wide acceptance throughout much of the world. According to thought leaders, this decade promises to be even more exciting. Paradigms will be shifted and innovation will accelerate to meet the remaining challenges of the aorta. New concepts will be introduced to facilitate repair close to and in the aortic arch, treat both types of dissecting aneurysms and revascularize vital branches while excluding aneurysms more effectively from circulation. During the rest of the decade, thoraco-abdominal aortic endovascular aneurysm repair (TAA-EVAR) with fenestrated, branched and hemodynamic repair devices, an emerging new modality that is gathering momentum, will be perfected and devices will become simpler to use, stockable in off-the- shelf configurations and widely adopted. A new generation of devices that further expands the universe of patients eligible for endovascular repair will rollout in major markets so that before the end of the decade close to 90% of aortic aneurysm patients will be treated endovascularly. Hemodynamic repair of thoraco-abdominal aneurysms is a particularly disruptive technology platform. No fenestrations, no branches and the blood simply goes where it should. If the technology proves effective, it might make other more complicated technologies unnecessary. The Aortic Intervention Market Report attempts to answer some important questions regarding the fast evolving aortic intervention landscape. The report, which takes a novel disease management approach to the sector, analyzes revenue and growth trends for the entire market with special emphasis on major disease areas. Aortic Intervention Market Report examines Leading companies technologies, product offerings, market shares and strategic positions, uncovers areas with maturing trends as well as areas with high growth potential and provides an updated vision to 2020. With Aortic Intervention Market Report you'll be better able to: - Examine new strategic landscape and understand evolving market dynamics. - Assess market size and growth rates of leading device segments. - Re-assess market potential and have access to updated forecast. - Understand current market situation, competitors' positions and market shares. - Identify emerging technologies and the companies behind them. - Leverage your own technology and brainstorm new business opportunities. - Monitor the competition's marketed and in-development products. - Investigate mergers, acquisitions and licensing possibilities. Aortic Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this one billion dollar fast growing market. For more information visit http://www.researchandmarkets.com/research/t786w4/aortic
ENG: 1.83 (-0.01)
ENGlobal CorporationCorporate Event Announcement Notice
Wall Street Horizon - Thu Dec 19, 7:51PM CST
Trading resumes in:
ENG: 1.83 (-0.01)
